We are monitoring the impact of COVID-19 & Recession alarm on Sepsis Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Global Sepsis Diagnostics Market Size, Share, Trends, COVID-19 impact and Growth Analysis Report – Segmented By Pathogen, Product, Technology, Method, Usability and Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 2821
Pages: 175

Sepsis Diagnostics Market Size (2022 to 2027)

As per our research report, the global sepsis diagnostics market size was worth USD 1014 million in 2022 and is estimated to be growing at a CAGR of 8.51% to reach USD 1525 million by 2027. The increasing prevalence of the disease and its fatal effects have stimulated its growth.

Sepsis Diagnostics Market

Sepsis is the body’s reaction to the bacteria, fungal, viral, or plastic infection, leading to the systemic inflammatory response, organ failure, or organ dysfunction.  Sepsis is emerging as a leading cause of mortality around the globe. As a result, the market players are launching advanced technological products to ensure sepsis diagnosis at the initial stages. Moreover, companies enter mergers and acquisitions to operate research and development activities and expand nationwide market growth.

As per the reports, some products have already been introduced in the United States in food and drug administration for diagnosis purposes. According to the Centers for disease control and prevention, it is estimated that 1.7 million people suffer from hospital-acquired infections (HAI) every year in the United States. As per the ECDC, 2013, around 4.1 million patients were diagnosed with HAI in Europe. However, developed countries with advanced facilities and fewer sepsis cases have been recorded in the study of more than 7000 patient outcomes using the Early Sense systems. The number of ICU days for transferred cases has decreased by 46%. 

Impact of COVID-19 on the global sepsis diagnostics market:

The COVID-19 pandemic had a moderate positive impact on sales of diagnostic products for sepsis. The worldwide spread of Covid-19 and new cases of sepsis in Covid-19 patients have forced the leading healthcare solution suppliers to develop sepsis diagnostic technologies. The pandemic outbreak increases the demand for rapid diagnosis and accelerates the use of equipment, reagents, and assay kits to detect sepsis. The movement restrictions caused by the pandemic delayed people's health examinations, affecting the number of tests performed and the sale of reagents. The current COVID-19 pandemic highlights the risks faced by older people prone to complications such as acute respiratory distress syndrome due to pneumonia, which increases the risk of sepsis. Therefore, there is an increasing need for the early diagnosis of sepsis in patients with COVID-19 infection.

MARKET DRIVERS:

The growth of the global sepsis diagnostic market is anticipated to be driven by factors such as the growing burden of infectious diseases and an increasing number of sepsis incidences globally.

According to thelancet.com, an estimated 48.9 million sepsis cases were identified in 2017, in which 11.0 sepsis-related deaths were recorded. People with weak immune systems and chronic diseases such as diabetes, cancer, and AIDS are vulnerable to contracting sepsis, which is expected to drive market growth. In the US, sepsis amongst hospitalized sufferers is growing by 8.7% each year. It is anticipated that there are more than a million cases of sepsis amongst hospitalized sufferers yearly, driving the need for sepsis tests. The continuous expenditure in the healthcare sector is also boosting its infrastructure, making sepsis tests accessible to more people. Many manufacturers of sepsis diagnosis are expanding their product offerings with point-of-care technology to detect sepsis quickly and reduce the time required for overall diagnosis. BACTEC Plus, BacT / Alert, and BACTEC FX blood culture equipment manufactured by BD Company (USA) are automated microbial detection systems that enable rapid diagnosis of sepsis. 

Hospital-received infections are a prime motive of morbidity and mortality worldwide. Urinary tract infections, pneumonia, and sepsis are the most common infections caused in hospitals. The senior population and people suffering from persistent illness are driving the demand for sepsis diagnostic products because they are more prone to hospital-received infections due to their weak immune systems.

Furthermore, the increasing prevalence of antibiotic-resistant bacterial strains and rising concern about the health of the people worldwide and growing healthcare expenditure is projected to improve the market growth. Government incentives and investment expenditure to improve healthcare propel the sepsis diagnostics market during the forecast period.

MARKET RESTRAINTS:

Sepsis is a potentially fatal illness that must be recognized and treated by trained health care professionals as soon as possible. Unfortunately, the global shortage of competent professionals and health workers is a big problem faced by the sepsis diagnostic market. As a result, almost half of the patients with severe sepsis transferred by the hospital system are accompanied by emergency medical care. On the other hand, the shortage of skilled emergency care workers affects all stages of patient care, including raising awareness of sepsis, assessing patients for sepsis diagnostic equipment, and making appropriate treatment decisions.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Pathogen, Product, Technology, Method, Usability, End-User, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This market research report on the global sepsis diagnostics market has been segmented and sub-segmented based on the pathogen, product, technology, method, usability, end-user, and region.

Sepsis Diagnostics Market Analysis – By Pathogen:

  • Bacterial Sepsis    
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis        
  • Other Pathogen Infections    

Based on the pathogen, the bacterial sepsis segment is forecasted to register the leading market share in the global sepsis diagnostics market during the forecast period. Since most patients suffering from blood poisoning are bacterial infections, the bacterial sepsis segment held the most significant share of the global sepsis diagnostics market in 2021. Gram-negative bacteria are the most frequent bacterial sepsis. Therefore, the gram-positive bacterial sepsis segment is anticipated to dominate the market during the forecast period. Extensive research and development activities and favorable regulatory approval of novel solutions are expected to support the segment growth.

Due to the rise of Candida infection resulting in septic poisoning, fungal sepsis should expand at an appealing CAGR. However, this disease comes from fewer viruses and parasites, so this segment accounted for a minimal share in 2020.         

Sepsis Diagnostics Market Analysis – By Product:

  • Instruments          
  • Blood Culture Media          
  • Assay Kits & Reagents       
  • Software   

Based on the product, Blood culture media was estimated to be the largest segment in 2020. It grows more rapidly over the forecast period because physicians know blood culture as the gold standard form and a cost-effective screening method. Most clinicians consider the blood culture media the cost-effective and standard method.

The assay kits and reagents segment will show lucrative growth due to their new diagnostic capability and the implementation of automated testing by significant companies.

Sepsis Diagnostics Market Analysis – By Technology:

  • Microbiology         
  • Molecular Diagnostics       
  • Immunoassays     
  • Flow Cytometry   
  • Other Technologies    

Based on technology, the microbiology segment dominated the global market, with the largest share of over 48.5%. This is because microbiological techniques allow the use of media tests to detect and identify microorganisms for the diagnosis of sepsis accurately. In addition, new strategic initiatives by key companies are driving the segment growth. For example, in April 2019, BD launched a new platelet quality control medium, BD BACTEC, to help detect and mitigate the occurrence of sepsis in patients undergoing platelet transfusions.  

Sepsis Diagnostics Market Analysis – By Method:

  • Conventional Diagnostics
  • Automated Diagnostics

Sepsis Diagnostics Market Analysis – By Usability:

  • Laboratory Testing              
  • Point-of-Care Testing     

Sepsis Diagnostics Market Analysis – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the North American sepsis diagnostics market occupied the most significant share of the global market in 2021. The region is expected to maintain its lead throughout the forecast period due to its established healthcare infrastructure and the increasing adoption of advanced diagnostic solutions. In addition, the strong presence of major regional companies and supportive redemption frameworks are driving the market growth. The United States holds a significant share in North America. Technological advancements, growing adoption of advanced diagnostic products, and high healthcare expenditure.

The European sepsis diagnostics market is projected to grow significantly from 2022 to 2027. The European market held the second-largest share of revenue in the global market in 2021. High incidence of healthcare expenditure and advanced medical procedures have augmented market growth. 

The sepsis diagnostics market in the Asia Pacific is the quickest growing region globally and is predicted to grow at a healthy rate during the forecast period. Improving healthcare infrastructure facilities, the availability of advanced diagnostic products, favorable government initiatives, and the rise in healthcare expenditure influence market growth in this region. In addition, the demand for sepsis diagnostic solutions is increasing in countries with a high prevalence of infectious diseases. The countries like China, Japan, and India significantly contribute to the APAC regional market growth.

The Latin American sepsis diagnostics market is predicted to rise at a CAGR of 8.92% from 2022 to 2027.

The sepsis diagnostics market in the Middle East & Africa was valued at USD 35.36 million in 2022, owing to the growing burden of infectious diseases. It is further projected to grow steadily during the forecast period. The increasing number of sepsis incidences in this region and raising awareness among healthcare people augment market growth.

KEY MARKET PARTICIPANTS AND SHARE INSIGHTS:

Some notable companies operating in the global sepsis diagnostics market are BioMérieux SA, T2 Biosystems Inc., Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc., Abbott Laboratories, and Roche Diagnostics Limited, Becton Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

In April 2018, Curetis NV collaborated with partner Acumen Research Laboratories Pte. Ltd and received approval for Unyvero BCU Cartridge for bloodstream infections in Singapore.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Global Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  2. Global Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  3. Global Bacterial Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  4. Global Fungal Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  5. Global Other Pathogen Infections Market, By Region, From 2022 - 2027 (USD Billion)
  6. Global Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  7. Global Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  8. Global Blood Culture Media Market, By Region, From 2022 - 2027 (USD Billion)
  9. Global Assay Kits and Reagents Market, By Region, From 2022 - 2027 (USD Billion)
  10. Global Software Market, By Region, From 2022 - 2027 (USD Billion)
  11. Global Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  12. Global Molecular Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  13. Global Microbiology Market, By Region, From 2022 - 2027 (USD Billion)
  14. Global Immunoassay Market, By Region, From 2022 - 2027 (USD Billion)
  15. Global Flow Cytometry Market, By Region, From 2022 - 2027 (USD Billion)
  16. Global Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  17. Global Conventional Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  18. Global Automated Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  19. Global Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  20. Global Laboratory Testing Market, By Region, From 2022 - 2027 (USD Billion)
  21. Global Point-of-Care Testing Market, By Region, From 2022 - 2027 (USD Billion)
  22. North America Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  23. North America Bacterial Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  24. North America Fungal Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  25. North America Other Pathogen Infections Market, By Region, From 2022 - 2027 (USD Billion)
  26. North America Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  27. North America Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  28. North America Blood Culture Media Market, By Region, From 2022 - 2027 (USD Billion)
  29. North America Assay Kits and Reagents Market, By Region, From 2022 - 2027 (USD Billion)
  30. North America Software Market, By Region, From 2022 - 2027 (USD Billion)
  31. North America Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  32. North America Molecular Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  33. North America Microbiology Market, By Region, From 2022 - 2027 (USD Billion)
  34. North America Immunoassay Market, By Region, From 2022 - 2027 (USD Billion)
  35. North America Flow Cytometry Market, By Region, From 2022 - 2027 (USD Billion)
  36. North America Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  37. North America Conventional Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  38. North America Automated Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  39. North America Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  40. North America Laboratory Testing Market, By Region, From 2022 - 2027 (USD Billion)
  41. North America Point-of-Care Testing Market, By Region, From 2022 - 2027 (USD Billion)
  42. United States Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  43. United States Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  44. United States Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  45. United States Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  46. United States Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  47. Canada Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  48. Canada Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  49. Canada Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  50. Canada Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  51. Canada Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  52. Europe Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  53. Europe Bacterial Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  54. Europe Fungal Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  55. Europe Other Pathogen Infections Market, By Region, From 2022 - 2027 (USD Billion)
  56. Europe Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  57. Europe Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  58. Europe Blood Culture Media Market, By Region, From 2022 - 2027 (USD Billion)
  59. Europe Assay Kits and Reagents Market, By Region, From 2022 - 2027 (USD Billion)
  60. Europe Software Market, By Region, From 2022 - 2027 (USD Billion)
  61. Europe Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  62. Europe Molecular Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  63. Europe Microbiology Market, By Region, From 2022 - 2027 (USD Billion)
  64. Europe Immunoassay Market, By Region, From 2022 - 2027 (USD Billion)
  65. Europe Flow Cytometry Market, By Region, From 2022 - 2027 (USD Billion)
  66. Europe Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  67. Europe Conventional Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  68. Europe Automated Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  69. Europe Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  70. Europe Laboratory Testing Market, By Region, From 2022 - 2027 (USD Billion)
  71. Europe Point-of-Care Testing Market, By Region, From 2022 - 2027 (USD Billion)
  72. U.K. Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  73. U.K. Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  74. U.K. Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  75. U.K. Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  76. U.K. Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  77. Germany Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  78. Germany Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  79. Germany Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  80. Germany Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  81. Germany Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  82. France Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  83. France Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  84. France Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  85. France Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  86. France Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  87. Italy Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  88. Italy Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  89. Italy Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  90. Italy Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  91. Italy Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  92. Spain Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  93. Spain Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  94. Spain Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  95. Spain Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  96. Spain Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  97. Asia-Pacific Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  98. Asia-Pacific Bacterial Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  99. Asia-Pacific Fungal Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  100. Asia-Pacific Other Pathogen Infections Market, By Region, From 2022 - 2027 (USD Billion)
  101. Asia-Pacific Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  102. Asia-Pacific Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  103. Asia-Pacific Blood Culture Media Market, By Region, From 2022 - 2027 (USD Billion)
  104. Asia-Pacific Assay Kits and Reagents Market, By Region, From 2022 - 2027 (USD Billion)
  105. Asia-Pacific Software Market, By Region, From 2022 - 2027 (USD Billion)
  106. Asia-Pacific Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  107. Asia-Pacific Molecular Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  108. Asia-Pacific Microbiology Market, By Region, From 2022 - 2027 (USD Billion)
  109. Asia-Pacific Immunoassay Market, By Region, From 2022 - 2027 (USD Billion)
  110. Asia-Pacific Flow Cytometry Market, By Region, From 2022 - 2027 (USD Billion)
  111. Asia-Pacific Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  112. Asia-Pacific Conventional Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  113. Asia-Pacific Automated Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  114. Asia-Pacific Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  115. Asia-Pacific Laboratory Testing Market, By Region, From 2022 - 2027 (USD Billion)
  116. Asia-Pacific Point-of-Care Testing Market, By Region, From 2022 - 2027 (USD Billion)
  117. Japan Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  118. Japan Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  119. Japan Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  120. Japan Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  121. Japan Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  122. China Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  123. China Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  124. China Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  125. China Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  126. China Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  127. India Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  128. India Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  129. India Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  130. India Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  131. India Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  132. Australia Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  133. Australia Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  134. Australia Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  135. Australia Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  136. Australia Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  137. South Korea Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  138. South Korea Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  139. South Korea Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  140. South Korea Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  141. South Korea Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  142. Latin America Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  143. Latin America Bacterial Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  144. Latin America Fungal Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  145. Latin America Other Pathogen Infections Market, By Region, From 2022 - 2027 (USD Billion)
  146. Latin America Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  147. Latin America Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  148. Latin America Blood Culture Media Market, By Region, From 2022 - 2027 (USD Billion)
  149. Latin America Assay Kits and Reagents Market, By Region, From 2022 - 2027 (USD Billion)
  150. Latin America Software Market, By Region, From 2022 - 2027 (USD Billion)
  151. Latin America Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  152. Latin America Molecular Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  153. Latin America Microbiology Market, By Region, From 2022 - 2027 (USD Billion)
  154. Latin America Immunoassay Market, By Region, From 2022 - 2027 (USD Billion)
  155. Latin America Flow Cytometry Market, By Region, From 2022 - 2027 (USD Billion)
  156. Latin America Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  157. Latin America Conventional Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  158. Latin America Automated Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  159. Latin America Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  160. Latin America Laboratory Testing Market, By Region, From 2022 - 2027 (USD Billion)
  161. Latin America Point-of-Care Testing Market, By Region, From 2022 - 2027 (USD Billion)
  162. Brazil Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  163. Brazil Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  164. Brazil Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  165. Brazil Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  166. Brazil Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  167. Argentina Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  168. Argentina Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  169. Argentina Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  170. Argentina Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  171. Argentina Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  172. Mexico Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  173. Mexico Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  174. Mexico Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  175. Mexico Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  176. Mexico Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  177. Rest of Latin America Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  178. Rest of Latin America Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  179. Rest of Latin America Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  180. Rest of Latin America Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  181. Rest of Latin America Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  182. Middle East & Africa Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  183. Middle East & Africa Bacterial Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  184. Middle East & Africa Fungal Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  185. Middle East & Africa Other Pathogen Infections Market, By Region, From 2022 - 2027 (USD Billion)
  186. Middle East & Africa Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  187. Middle East & Africa Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  188. Middle East & Africa Blood Culture Media Market, By Region, From 2022 - 2027 (USD Billion)
  189. Middle East & Africa Assay Kits and Reagents Market, By Region, From 2022 - 2027 (USD Billion)
  190. Middle East & Africa Software Market, By Region, From 2022 - 2027 (USD Billion)
  191. Middle East & Africa Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  192. Middle East & Africa Molecular Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  193. Middle East & Africa Microbiology Market, By Region, From 2022 - 2027 (USD Billion)
  194. Middle East & Africa Immunoassay Market, By Region, From 2022 - 2027 (USD Billion)
  195. Middle East & Africa Flow Cytometry Market, By Region, From 2022 - 2027 (USD Billion)
  196. Middle East & Africa Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  197. Middle East & Africa Conventional Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  198. Middle East & Africa Automated Sepsis Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  199. Middle East & Africa Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  200. Middle East & Africa Laboratory Testing Market, By Region, From 2022 - 2027 (USD Billion)
  201. Middle East & Africa Point-of-Care Testing Market, By Region, From 2022 - 2027 (USD Billion)
  202. Middle East Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  203. Middle East Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  204. Middle East Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  205. Middle East Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  206. Middle East Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)
  207. Africa Sepsis Diagnostics Market, By Pathogen, From 2022 - 2027 (USD Billion)
  208. Africa Sepsis Diagnostics Market, By Products, From 2022 - 2027 (USD Billion)
  209. Africa Sepsis Diagnostics Market, By Technology, From 2022 - 2027 (USD Billion)
  210. Africa Sepsis Diagnostics Market, By Method, From 2022 - 2027 (USD Billion)
  211. Africa Sepsis Diagnostics Market, By Usability, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

FAQ's

How much is the global sepsis diagnostics market going to be worth by 2027?

The global sepsis diagnostics market size is estimated to be worth USD 1525 million by 2027.

Does this report include the impact of COVID-19 on the sepsis diagnostics market?

Yes, we have studied and included the COVID-19 impact on the global sepsis diagnostics market in this report.

Which segment by pathogen led the sepsis diagnostics market in 2021?

Based on the pathogen, the bacterial sepsis segment accounted for the largest share of the sepsis diagnostics market in 2021. 

Which are the most dominating companies in the sepsis diagnostics market?

BioMérieux SA, T2 Biosystems Inc., Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc., Abbott Laboratories, and Roche Diagnostics Limited, Becton Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc. are some of the major companies in the sepsis diagnostics market.

Related Reports

PURCHASE OPTIONS

excel
$

4255


pdf excel
$

5060


pdf excel powerbi
$

7360


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample